Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2025-01-01T00:01:20.448Z Has data issue: false hasContentIssue false
  • English
  • Français

Tuberculin Skin Testing Among Healthcare Workers in the University of Malaya Medical Centre, Kuala Lumpur, Malaysia

Published online by Cambridge University Press:  02 January 2015

Lian-HuatTan ,
Adeeba Kamarulzaman ,
Chong-Kin Iiam  and
Toong-Chow Lee
Lian-HuatTan*
Affiliation:
Infectious Diseases Division, Department of Medicine, University of Malaya Medical Centre, Kuala Lumpur, Malaysia
Adeeba Kamarulzaman
Affiliation:
Infectious Diseases Division, Department of Medicine, University of Malaya Medical Centre, Kuala Lumpur, Malaysia
Chong-Kin Iiam
Affiliation:
Respiratory Diseases Division, Department of Medicine, University of Malaya Medical Centre, Kuala Lumpur, Malaysia
Toong-Chow Lee
Affiliation:
Clinical Investigation Centre, University of Malaya Medical Centre, Kuala Lumpur, Malaysia
*
Department of Medicine, University of Malaya Medical Centre, 59100, Kuala Lumpur, Malaysia
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives:

To determine the occupational risk of Mycobacterium tuberculosis infection among healthcare workers (HCWs) and to examine the utility of tuberculin skin testing in a developing country with a high prevalence of bacille Calmette-Guerin vaccination.

Design:

Tuberculin skin test (TST) survey.

Setting:

A tertiary-care referral center and a teaching hospital in Kuala Lumpur, Malaysia.

Participants:

HCWs from medical, surgical, and orthopedic wards.

Intervention:

Tuberculin purified protein derivative RT-23 (State Serum Institute, Copenhagen, Denmark) was used for the TST (Mantoux method).

Results:

One hundred thirty-seven (52.1%) and 69 (26.2%) of the HCWs tested had indurations of 10 mm or greater and 15 mm or greater, respectively. Medical ward HCWs were at significantly higher risk of a positive TST reaction than were surgical or orthopedic ward HCWs (odds ratio, 2.18; 95% confidence interval, 1.33 to 3.57; P = .002 for TST positivity at 10 mm or greater) (odds ratio, 2.61; 95% confidence interval, 1.44 to 4.70; P = .002 for TST positivity at 15 mm or greater). A previous TST was a significant risk factor for a positive TST reaction at either 10 mm or greater or 15 mm or greater, but a duration of employment of more than 1 year and being a nurse were only significantly associated with a positive TST reaction at a cut-off point of 15 mm or greater.

Conclusions:

HCWs at the University of Malaya Medical Centre had an increased risk for M. tuberculosis infection that was significantly associated with the level of occupational tuberculosis exposure. A TST cut-off point of 15 mm or greater may correlate better with M. tuberculosis infection than a cut-off point of 10 mm or greater in settings with a high prevalence of bacille Calmette-Guerin vaccination (Infect Control Hosp Epidemiol 2002;23:584-590).

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 23 , Issue 10 , October 2002 , pp. 584 - 590
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2002

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Sepkowitz, KA. Tuberculosis and the health care worker: a historical perspective. Ann Intern Med 1994;120:71–79.Google Scholar
2.Beck-Sague, C, Dooley, SW, Hutton, MD, et alHospital outbreak of multidrug-resistant Mycobacterium tuberculosis infection: factors in transmission to staff and HIV-infected patients. JAMA 1992;268:1280–1286.CrossRefGoogle ScholarPubMed
3.Menzies, D, Fanning, A, Yuan, L, Fitzgerald, M. Tuberculosis among health care workers. N Engl J Med 1995;332:92–98.Google Scholar
4.Edlin, BR, Tokars, JI, Grieco, MH, et alAn outbreak of multiresistant tuberculosis among hospitalized patients with acquired immunodeficiency syndrome. N Engl J Med 1992;326:1514–1521.CrossRefGoogle Scholar
5.Dooley, SW, Villarino, ME, Lawrence, M, et alNosocomial transmission of tuberculosis in a hospital unit for HIV-infected patients. JAMA 1992;267:1632–1635.CrossRefGoogle Scholar
6.Pearson, ML, Jereb, JA, Frieden, TR, et alNosocomial transmission of multidrug-resistant Mycobacterium tuberculosis: a risk to patients and health care workers. Ann Intern Med 1992;117:191–196.CrossRefGoogle ScholarPubMed
7.Jarvis, WR. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. Am J Infect Control 1995;23:146–151.CrossRefGoogle ScholarPubMed
8.Jereb, JA, Hevens, RM, Privett, TD, et alTuberculosis in health care workers at a hospital with an outbreak of multi-drug resistant Mycobacterium tuberculosis. Arch Intern Med 1995;155:854–859.CrossRefGoogle Scholar
9.Barnes, PF, Bloch, AB, Davidson, FT, Snider, DE Jr. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1991;324:1644–1650.Google Scholar
10.Harries, AD. Tuberculosis and human immunodeficiency virus infection in developing countries. Lancet 1990;335:387–390.CrossRefGoogle ScholarPubMed
11.Ritacco, V, Di Lonardo, M, Reniero, A, et alNosocomial spread of human immunodeficiency virus-related multidrug-resistant tuberculosis in Buenos Aires. J Infect Dis 1997;176:637–642.Google Scholar
12.Muzzy de Souza, GR, Cravo, R, Figueira, MM, et alTuberculin conversion among health care workers in a general hospital of Rio de Janeiro, Brazil: final results. Am J Respir Crit Care Med 1998;157:705.Google Scholar
13.Sidibe, K, Zuber, P, Wiktor, SZ, et alTuberculin skin test reactivity among health care workers and level of exposure to tuberculosis patients in Abidjan, Cote d'voire. Int J Tuberc Lung Dis 1997;1(suppl):S103.Google Scholar
14.Wilkinson, D, Crump, J, Pillay, M, Sturm, AW. Nosocomial transmission of tuberculosis in Africa documented by restriction fragment length polymorphism. Trans R Soc Trop Med Hyg 1997;91:318.Google Scholar
15.World Health Organization. Guideline for the Prevention of Tuberculosis in Health Care Facilities in Resource-Limited Settings. Geneva: World Health Organization; 1999.Google Scholar
16.World Health Organization. Global TB Control: WHO Report 2000. Geneva: World Health Organization; 2000.Google Scholar
17.Sepkowitz, KA. Tuberculosis in the 21st century. Emerg Infect Dis 2001;7:259–262.CrossRefGoogle Scholar
18.Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health care facilities. MMWR 1994;43(RR-13):1–132.Google Scholar
19.American Thoracic Society, Centers for Disease Control and Prevention. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000;161:1376–1395.Google Scholar
20.Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161:S221–S247.CrossRefGoogle Scholar
21.Do, AN, Limpakarnjarat, W, Uthaivoravit, PLF, et alIncreased risk of Mycobacterium tuberculosis infection related to the occupational exposures of health care workers in Chiang Rai, Thailand. Int J Tuberc Lung Dis 1999;3:377–381.Google Scholar
22.Molina-Gamboa, JD, Ponce-de-Leon-Rosales, S, Rivera-Morales, I, et alEvaluation of the sensitivity of RT-23 purified protein derivative for determining tuberculin reactivity in a group of health care workers. Clin Infect Dis 1994;19:784–786.CrossRefGoogle Scholar
23.Molina-Gamboa, J, Fivera-Morales, I, Ponce-de-Leon-Rosales, S. Prevalence of tuberculin reactivity among healthcare workers from a Mexican hospital. Infect Control Hosp Epidemiol 1994;15:319–320.CrossRefGoogle ScholarPubMed
24.Rangel-Frausto, MS, Ponce-de-Leon-Rosales, S, Martinez-Abaroa, C, Haslov, K. Tuberculosis and tuberculin quality: best intentions, misleading results. Infect Control Hosp Epidemiol 2001;22:481–484.CrossRefGoogle ScholarPubMed
25.Huebner, RE, Schein, MF, Bass, JB Jr. The tuberculin skin test. Clin Infect Dis 1993;17:968–975.Google Scholar
26.World Health Organization. Tuberculin. Bull World Health Organ 1958; 19:759–952.Google Scholar
27.Snider, DE Jr. Bacille Calmette-Guerin vaccinations and tuberculin skin tests. JAMA 1985;253:3438–3439.Google Scholar
28.Sepulveda, RL, Ferrer, X, Latrach, C, Sorensen, RU. The influence of Calmette-Guerin bacillus immunization on the booster effect of tuberculin testing in healthy young adults. American Review of Respiratory Disease 1990;142:24–28.Google Scholar
29.Menzies, R, Vissandjee, B. Effect of bacille Calmette-Guerin vaccination on tuberculin reactivity. American Review of Respiratory Disease 1992;145:621–625.Google Scholar
30.Haslov, K, Ponce-de-Leon-Rosales, S, Rangel-Frausto, S, Olesen Larsen, S. Tuberculin PPD RT-23: still going strong. Int J Tuberc Lung Dis. 1998; 2:793–795.Google Scholar
31.Teixeira, L, Maciel, E, Dutra, ME, Perkins, MD, Johnson, JL, do Valle Dettoni, V. Simultaneous comparison of reactivity to purified protein derivative RT-23 and Tubersol in health care workers in Vitoria, Brazil. Int J Tuberc Lung Dis 2000;4:1074–1077.Google Scholar
32.Kim, SJ, Hong, YP, Bai, GH, et alTuberculin PPD RT-23: has it lost some of its potency? Int J Tuberc Lung Dis 1998;2:857–860.Google Scholar
33.Maw, KL, Fujiwara, PI, Munsiff, SS. Prevalence of tuberculin skin test (TST) positivity and conversion rates among New York City Department of Health employees, 1994-1996. Int J Tuberc Lung Dis 1997;1(suppl): S103.Google Scholar
34.Stuart, RL, Bennett, N, Hart, W, et alMantoux testing of health care workers: the Melbourne Mantoux Test Study. Aust N Z J Med 1998;25:712.Google Scholar